Free Trial
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel
OTCMKTS:AMBBY

Ambu A/S Q3 2025 Earnings Results & Report

Ambu A/S logo
$11.00 0.00 (0.00%)
As of 10/9/2026

Ambu A/S reported Q3 2025 earnings on August 22, 2025. The company reported EPS of $0.07, while revenue was $229.16 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
Before Market Opens

Ambu A/S EPS Results

Actual EPS
$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Ambu A/S Revenue Results

Actual Revenue
$229.16 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Ambu A/S Q3 2025 Earnings FAQ

Ambu A/S (OTCMKTS:AMBBY) reported earnings of $0.07 per share for Q3 2025. The report was announced on Friday, August 22, 2025.

Ambu A/S reported revenue of $229.16 million for Q3 2025.

Ambu A/S Earnings Headlines

Ambu AS ADR AMBBY
August 28, 2026  |  morningstar.comM
3 European Stocks Estimated To Be Undervalued By Up To 47.6%
November 18, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/3-european-stocks-estimated-undervalued-053805496.html
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
October 11 at 1:00 AM  |  Profits Run (Ad)
European Growth Companies With Up To 34% Insider Ownership
November 14, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/european-growth-companies-34-insider-053539319.html
Ambu (CPSE:AMBU B) Valuation: How Improved Results and Guidance Shape Investor Sentiment
November 13, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/ambu-cpse-ambu-b-valuation-031456510.html
Did Strong Results and New Guidance Just Shift Ambu's (CPSE:AMBU B) Investment Narrative?
November 13, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/did-strong-results-guidance-just-111317861.html
See More Ambu A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ambu A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ambu A/S and other key companies, straight to your email.

About Ambu A/S

Ambu A/S (OTCMKTS:AMBBY) is a Danish medical device company that develops, manufactures and markets single-use products for hospitals, clinics and emergency care providers. Its portfolio includes disposable endoscopes and visualization systems used in areas such as bronchoscopy, gastrointestinal procedures, urology, ear, nose and throat care, and anesthesia.

The company also supplies products for airway management, patient monitoring and emergency care, including electrodes, resuscitation equipment and training manikins. Ambu’s single-use products are designed to support infection prevention, simplify clinical workflows and reduce the need for reprocessing reusable equipment.

Founded in 1937, Ambu has its headquarters in Ballerup, Denmark, and serves healthcare customers internationally through operations and distribution networks across Europe, North America, the Asia-Pacific region and other global markets. The company is led by Chief Executive Officer Britt Meelby Jensen.

View Ambu A/S Profile
Earnings Tools